PhaseBio Pharmaceuticals, Inc. (PHAS)
Short-Term Debt
$4.50M
Quarterly · Period ending: · USD
PHAS Short-Term Debt
Latest reported$4.50Mperiod ending
Latest reported$4.50Mperiod ending
PHAS Quarterly Short-Term Debt ($0.00 → $4.50M)
Quarterly short-term debt
High-resolution chart · PNG
PHAS short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 4,503,000 | |
| 5,875,000 | |
| 5,413,000 | |
| 5,884,000 | |
| 5,860,000 | |
| 5,838,000 | |
| 5,355,000 | |
| 5,341,000 | |
| 5,015,000 | |
| 3,686,000 | |
| 2,378,000 | |
| 1,990,000 | |
| 1,265,000 | |
| 423,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |